COA Workflow Batch-specific COA documents are matched to product and lot IDs inside the research portal
Tirzepatide: The Dual Incretin Receptor Agonist Tirzepatide has revolutionized metabolic therapy as the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA
CJC-1295 sustains elevated baseline GH through prolonged GHRH receptor engagement
Best Injection Sites Lower abdomen the most popular site
Storage & Handling Store Klow kits sealed at 28 C in a dry, dark place to maintain peptide stability during long-distance transport and storage
PMID: 6943836 opkov J, Padrov J, Romnkov V, Havlovicov M, Balakov M, Zelinov M, Vejvalkov , Simandlov M, tpnkov J, Honov V, Kantorov E, Kekov G, Pospilov J, Boday A, Meszarosov AU, Turnovec M, Votpka P, Likov P, Kremlkov PR